Food News and Research

RSS

Cornell Food and Brand Lab researchers explore Smarter Lunchrooms Initiative

How many more apples can a school cafeteria sell if the fruit is displayed in an attractive basket and placed in a well-lit area? That's the sort of question researchers from the Cornell Food and Brand Lab are exploring as part of their Smarter Lunchrooms Initiative-an effort to discover and share low-cost changes that can be made in lunchrooms to subtly guide smarter food choices.

5 Jun 2010

CSTE 2010 Annual Conference to focus on public health challenges

The Council of State and Territorial Epidemiologists 2010 Annual Conference will be held June 6-10 at the Oregon Convention Center in Portland, Oregon. An array of experts representing federal, state, and local health departments will discuss issues ranging from last year's flu pandemic, obesity, food safety, health care reform, information technology, and the global response to disasters such as the Haiti earthquake.

5 Jun 2010

EU sends $29M in food, medical aid to combat increasing food insecurity in Africa's Sahel region

The European Union on Wednesday sent $29 million worth of food and medical aid to help "millions facing hunger" across the drought-stricken Sahel region of West Africa, Reuters reports.

5 Jun 2010

Mylan subsidiary receives FDA approval for generic version of Neurontin Tablets

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Gabapentin Tablets USP, 600 mg and 800 mg, the generic version of Pfizer's Neurontin Tablets for the treatment of postherpetic neuralgia, a complication of shingles.

5 Jun 2010

TeleTracking Technologies, Sodexo announce multi-year renewal of sales partnership

TeleTracking Technologies and Sodexo, Inc. today announced a multi-year renewal of their long-standing sales partnership to bring automated patient flow and transport solutions to hospitals.

4 Jun 2010

Labopharm comments on the outcome of patent-infringement litigation related to Ultram ER

Labopharm Inc. today commented on the outcome of the appeal by Purdue Pharma Products L.P. and the cross-appeal by Par Pharmaceutical Companies, Inc. of the decision of the United States District Court for the District of Delaware in August 2009 on patent-infringement litigation initiated by Purdue against Par relating to Ultram ER (tramadol hydrochloride extended-release tablets).

4 Jun 2010

Bertucci’s Chef chosen to participate in First Lady Michelle Obama's Chefs Move To Schools program

Northborough, MA-based Bertucci’s Corporation announced today that it’s own Chef Stefano Cordova has been chosen by First Lady Michelle Obama to participate in her “Chefs Move To Schools” program that calls on the nation’s chefs to adopt a school, work with teachers, parents, school nutritionists and administrators to help educate kids about food and nutrition.

4 Jun 2010

Roche's new dual-PCR target HIV-1 viral load test receives FDA approval

Roche Molecular Diagnostics announced today that the Food and Drug Administration (FDA) approved its new dual-PCR target HIV-1 viral load test to quantify the amount of virus in a patient's blood. The COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0 is the first quantitative viral load test to amplify and detect two separate regions of a target genome and offers a fully automated and reliable solution for physicians to make informed treatment decisions for HIV-1 patients undergoing antiretroviral therapy.

4 Jun 2010

Researchers develop biosensors to monitor concentration of c-di-GMP within single living bacteria cells

Some species of bacteria perform an amazing reproductive feat. When the single-celled organism splits in two, the daughter cell - the swarmer - inherits a propeller to swim freely. The mother cell builds a stalk to cling to surfaces.

4 Jun 2010

Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemotherapy

Abraxis BioScience, Inc. announced today that findings from a phase 1 randomized trial demonstrated that the nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) is well-tolerated and active in the second-line treatment of high-grade, non-muscle-invasive bladder cancer that has been refractory to standard intra-bladder infusion (intravesical) therapy.

4 Jun 2010

Kidney dialysis patients unprepared for disasters: Study

Immediately after Hurricane Katrina in August 2005, the survival of more than 5,800 Gulf Coast kidney dialysis patients was threatened as the storm forced closure of 94 dialysis units. Within a month 148 of these patients had died.

4 Jun 2010

Advergames can promote unhealthy eating habits in children

UC Davis public health researchers have found that children, who are already saturated with television messages about unhealthy food choices, are the targets of a new medium used to sell high-fat, high-sugar foods: advergames.

4 Jun 2010

Study confirms Azilect as a selective MAO-B inhibitor

Teva Neuroscience Inc. today announced the publication of a study demonstrating the selectivity of Azilect® (rasagiline tablets) for inhibition of MAO-B (monoamine oxidase-B) at the maximum approved dose of 1 mg/day. The data was published in the Journal of Clinical Pharmacology OnlineFirst on May 5, 2010.

4 Jun 2010

New therapy mounts double-barreled attack on leukemia, report UF researchers

A new therapy mounts a double-barreled attack on leukemia, targeting not just the cancer cells but also the environment in which those cells live and grow, University of Florida researchers report.

4 Jun 2010

20% of returning war veterans report PTSD or major depression

This past Memorial Day honored those Americans who have died in military service including over 4,000 in Iraq and 1,000 fallen soldiers in Afghanistan. According to the latest Pentagon study, released in April this year, nearly 20 percent—or one in five returning war veterans—reported symptoms of post-traumatic stress disorder (PTSD) or major depression. The study also reports that approximately half of them sought treatment.

4 Jun 2010

Financial Times examines needs of smallholder farmers in developing countries

Reflecting on USAID's plans to reduce reliance on food aid to fight global hunger by investing in agricultural development through microloans, the Financial Times examines the needs of smallholder farmers throughout the world. The piece looks at the role that lenders and large suppliers can play in assisting smallholder farmers and ways to maximize the relationships between farmers and these groups.

4 Jun 2010

Sebelius to highlight geographic differences in Medicare hospital payments

U.S. Health and Human Services Secretary Kathleen Sebelius visits Rochester's Mayo Clinic Thursday morning. ... The visit comes after a recent report that Minnesota will receive money earmarked for states which provide low-cost, high-value health care. But just how much money Minnesota will receive is far from certain. Sebelius is expected to get a first-hand look at the clinic's technology for tracking health care information.

4 Jun 2010

FDA approves Perrigo's ANDA for OTC Miconazole Nitrate Vaginal Cream and Suppository

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Miconazole Nitrate Vaginal Cream and Suppository, a generic to Monistat® -1 Combination Pack. Perrigo expects to begin shipping immediately.

4 Jun 2010

FDA clears Abbott's new ARCHITECT HE4 assay for monitoring ovarian cancer

The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test of its kind available in the United States, uses a simple blood test to aid in monitoring for the recurrence or progression of this disease.

4 Jun 2010

Tioga commences dosing in Phase 3 trial of asimadoline for diarrhea-predominant irritable bowel syndrome

Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.

4 Jun 2010

Food News and Research

Cornell Food and Brand Lab researchers explore Smarter Lunchrooms Initiative

CSTE 2010 Annual Conference to focus on public health challenges

EU sends $29M in food, medical aid to combat increasing food insecurity in Africa's Sahel region

Mylan subsidiary receives FDA approval for generic version of Neurontin Tablets

TeleTracking Technologies, Sodexo announce multi-year renewal of sales partnership

Labopharm comments on the outcome of patent-infringement litigation related to Ultram ER

Bertucci’s Chef chosen to participate in First Lady Michelle Obama's Chefs Move To Schools program

Roche's new dual-PCR target HIV-1 viral load test receives FDA approval

Researchers develop biosensors to monitor concentration of c-di-GMP within single living bacteria cells

Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemotherapy

Kidney dialysis patients unprepared for disasters: Study

Advergames can promote unhealthy eating habits in children

Study confirms Azilect as a selective MAO-B inhibitor

New therapy mounts double-barreled attack on leukemia, report UF researchers

20% of returning war veterans report PTSD or major depression

Financial Times examines needs of smallholder farmers in developing countries

Sebelius to highlight geographic differences in Medicare hospital payments

FDA approves Perrigo's ANDA for OTC Miconazole Nitrate Vaginal Cream and Suppository

FDA clears Abbott's new ARCHITECT HE4 assay for monitoring ovarian cancer

Tioga commences dosing in Phase 3 trial of asimadoline for diarrhea-predominant irritable bowel syndrome

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News